Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
about
Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effectThe role of dysregulated glucose metabolism in epithelial ovarian cancer.HDAC inhibition decreases the expression of EGFR in colorectal cancer cells.A Review on the Relationship between SGLT2 Inhibitors and Cancer.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionThe association of apoptotic protein expressions sensitive to apoptosis gene, p73 and p53 with the prognosis of cervical carcinoma.Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresisResistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells.Ionizing radiation, ion transports, and radioresistance of cancer cellsPotential role of sugar transporters in cancer and their relationship with anticancer therapy.Biomarkers in the diagnosis and early detection of pancreatic cancer.The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors.Glycolytic genes in cancer cells are more than glucose metabolic regulators.Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma.EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis.Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma.Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma.Black bean peptides inhibit glucose uptake in Caco-2 adenocarcinoma cells by blocking the expression and translocation pathway of glucose transporters.Tumor suppressor gene adenomatous polyposis coli downregulates intestinal transport
P2860
Q26745461-BCC1FCF0-08E0-4468-B3E2-B1CF698D3379Q33674221-54D0F66E-C5E8-48E1-8EA1-B2C183C886FCQ33862612-CE5FBAFE-66A6-48B3-8579-FF35CCEB0A21Q34181385-65751C8C-4557-4BB4-850D-A237CC5C8670Q34459681-AB7EC253-31E9-43F4-9B4F-78F475F32BDFQ34610533-516EDADE-9ADB-492B-8B52-61A792C88D93Q36881828-FBB9258D-35A4-49B7-96CF-1E3D278CC1CAQ36907096-429754DE-F4EA-4369-B70E-AA1CDB5FB77BQ37095176-F58B8E67-B773-47CF-B086-BF2C6CD45224Q37779733-55F2AC16-AE17-4989-8110-5E537D1E315BQ38089821-0D693BBB-65D7-4E49-A3E8-8F763585DCCCQ38126109-2A851EF4-523C-4B7C-926F-FF1924C78919Q38218297-2F6885EC-27B3-499B-AC90-410A0DA349A4Q38406543-ED480649-85D0-4306-8A5C-32AA204D4990Q38554153-2175D64E-BA1C-4C9E-A32D-806D4312809FQ39139802-200531CC-5070-43E5-9301-1AFB3F3B553DQ39312047-39CFD077-1C8C-4EF4-8F44-3563974F1F61Q49271879-826AD83E-AC32-4C87-9CF4-5DC175A3BAABQ49461731-069ACB02-8E07-4954-92AF-F69CC4EE59A3Q50074585-9A982A9B-1A03-4179-AEA6-A441957B4786Q51511748-B4D905AF-24C6-4F12-839E-DFCD1D39CD06Q54945613-5D56BB20-BC5C-45EE-A433-66E73A21AEAEQ58484730-557F02FD-B137-45B3-A660-B36EDADF5BA0
P2860
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@ast
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@en
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@nl
type
label
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@ast
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@en
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@nl
prefLabel
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@ast
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@en
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
@nl
P2093
P2860
P1433
P1476
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
@en
P2093
Bernard de Hemptinne
Christophe Van de Wiele
Martine De Vos
Nancy Van Damme
Patrick Pauwels
Philippe Fonteyne
Pieter Demetter
Veerle F Casneuf
P2860
P304
P356
10.1080/07357900801956363
P50
P577
2008-10-01T00:00:00Z